DocuSign, Inc. (NASDAQ:DOCU) Shares Sold by Brighton Jones LLC

Brighton Jones LLC trimmed its position in DocuSign, Inc. (NASDAQ:DOCU) by 17.0% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 8,359 shares of the company’s stock after selling 1,712 shares during the period. Brighton Jones LLC’s holdings in DocuSign were worth $752,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Modus Advisors LLC acquired a new stake in shares of DocuSign in the fourth quarter valued at $36,000. Itau Unibanco Holding S.A. bought a new position in shares of DocuSign during the 3rd quarter valued at about $28,000. Brooklyn Investment Group bought a new position in shares of DocuSign during the 3rd quarter valued at about $33,000. Avior Wealth Management LLC grew its stake in shares of DocuSign by 36.5% in the 4th quarter. Avior Wealth Management LLC now owns 542 shares of the company’s stock worth $49,000 after purchasing an additional 145 shares during the last quarter. Finally, Friedenthal Financial bought a new stake in shares of DocuSign in the 4th quarter worth approximately $54,000. 77.64% of the stock is owned by institutional investors.

DocuSign Stock Performance

Shares of DOCU opened at $91.60 on Friday. DocuSign, Inc. has a 52 week low of $48.70 and a 52 week high of $107.86. The company has a market capitalization of $18.51 billion, a PE ratio of 18.89, a PEG ratio of 8.30 and a beta of 0.88. The company’s 50 day moving average price is $89.76 and its 200 day moving average price is $71.43.

Insider Activity

In other news, Director Peter Solvik sold 10,000 shares of DocuSign stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $91.26, for a total transaction of $912,600.00. Following the completion of the sale, the director now directly owns 150,253 shares in the company, valued at $13,712,088.78. The trade was a 6.24 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Allan C. Thygesen sold 7,764 shares of the business’s stock in a transaction that occurred on Friday, November 1st. The shares were sold at an average price of $69.95, for a total value of $543,091.80. Following the completion of the sale, the chief executive officer now directly owns 107,825 shares of the company’s stock, valued at approximately $7,542,358.75. The trade was a 6.72 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 693,537 shares of company stock worth $66,575,817 in the last ninety days. Corporate insiders own 1.66% of the company’s stock.

Analysts Set New Price Targets

DOCU has been the topic of several recent research reports. UBS Group lifted their price target on shares of DocuSign from $60.00 to $100.00 and gave the stock a “neutral” rating in a research report on Friday, December 6th. Wells Fargo & Company lifted their target price on DocuSign from $50.00 to $70.00 and gave the stock an “underweight” rating in a report on Friday, December 6th. Robert W. Baird increased their price target on DocuSign from $59.00 to $100.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. HSBC reissued a “reduce” rating on shares of DocuSign in a research note on Friday, December 6th. Finally, JPMorgan Chase & Co. upped their price objective on shares of DocuSign from $50.00 to $70.00 and gave the company an “underweight” rating in a research note on Tuesday, December 3rd. Three research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $92.45.

DocuSign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.